QCM : Understanding Hemostasis and Coagulation — 9 questions

Question 1

1. What is an antiplatelet agent?

A compound that enhances fibrin formation during clotting.

A substance that increases the production of platelets in the bone marrow.

A medication that inhibits platelet activation and aggregation to prevent arterial thrombosis.

A drug that dissolves existing blood clots in the veins.

Explication

An antiplatelet agent is a medication that inhibits platelet activation and aggregation, thereby reducing the formation of arterial clots. They are used to prevent events like heart attacks and strokes caused by arterial thrombosis. The other options describe different types of drugs or processes: clot dissolvers (thrombolytics), agents that increase platelet count, and substances that promote fibrin formation, none of which define antiplatelet agents.

Answer

A medication that inhibits platelet activation and aggregation to prevent arterial thrombosis.

Question 2

2. What are the three main stages involved in the hemostasis process?

Vascular constriction, platelet aggregation, and coagulation

Vessel dilation, clot dissolution, and fibrinolysis

Immune response, inflammation, and tissue regeneration

Vessel dilation, platelet activation, and fibrinolysis

Explication

Hemostasis involves vascular constriction to reduce blood flow, platelet plug formation, and coagulation to form a stable clot, all working sequentially to prevent bleeding.

Answer

Vascular constriction, platelet aggregation, and coagulation

Question 3

3. Which of the following clotting factors is vitamin K-dependent and plays a crucial role in the coagulation cascade?

Factor XIII

Factor I (Fibrinogen)

Factor VIII

Factor II (Prothrombin)

Explication

Factor II, also known as prothrombin, is a vitamin K-dependent clotting factor that is essential in the coagulation cascade. It is converted into thrombin, which then converts fibrinogen into fibrin to form a clot. Factors I (fibrinogen) and XIII are not vitamin K-dependent, and Factor VIII is part of the intrinsic pathway but is not vitamin K-dependent.

Answer

Factor II (Prothrombin)

Question 4

4. Which pathway of the coagulation cascade is triggered by exposure of tissue factor (Factor III)?

Intrinsic pathway

Extrinsic pathway

Common pathway

Fibrinolytic pathway

Explication

The extrinsic pathway is initiated when tissue injury exposes tissue factor, which then activates Factor VII, leading to the coagulation process.

Answer

Extrinsic pathway

Question 5

5. What is the primary role of anticoagulant classes in clinical therapy?

To increase platelet aggregation

To prevent the formation of new blood clots

To dissolve existing blood clots

To promote blood clotting in bleeding disorders

Explication

Anticoagulant classes are primarily used to prevent the formation of new blood clots and the extension of existing clots, thereby reducing the risk of thromboembolic events. They do not dissolve clots (which is the role of thrombolytics), nor do they promote clotting or increase platelet aggregation; in fact, they inhibit clot formation and platelet aggregation to prevent thrombosis.

Answer

To prevent the formation of new blood clots

Question 6

6. What is the primary function of thrombin in the coagulation cascade?

Converts fibrinogen into fibrin

Activates platelets

Breaks down fibrin clots

Inhibits clot formation

Explication

Thrombin (Factor IIa) plays a central role by converting fibrinogen into fibrin, which forms the mesh that stabilizes blood clots.

Answer

Converts fibrinogen into fibrin

Question 7

7. Which of the following factors is NOT involved in the intrinsic pathway?

Factor XII

Factor VIII

Factor VII

Factor XI

Explication

Factor VII is part of the extrinsic pathway, while factors XII, VIII, and XI are involved in the intrinsic pathway.

Answer

Factor VII

Question 8

8. What clinical marker is used to monitor warfarin therapy?

INR

aPTT

D-dimer

PTT

Explication

The INR (International Normalized Ratio) is used to monitor warfarin therapy, as it standardizes prothrombin time to assess anticoagulation effectiveness.

Answer

Vitamin K antagonists

Question 9

9. Which class of anticoagulants includes drugs like warfarin and acts by inhibiting vitamin K-dependent clotting factors?

Vitamin K antagonists

Direct oral anticoagulants (DOACs)

Heparins

Antiplatelet agents

Explication

Warfarin is a vitamin K antagonist that inhibits the synthesis of vitamin K-dependent clotting factors, affecting the coagulation cascade.

QCM : Understanding Hemostasis and Coagulation — 9 questions

Questions et réponses du QCM

1. What is an antiplatelet agent?

2. What are the three main stages involved in the hemostasis process?

3. Which of the following clotting factors is vitamin K-dependent and plays a crucial role in the coagulation cascade?

4. Which pathway of the coagulation cascade is triggered by exposure of tissue factor (Factor III)?

5. What is the primary role of anticoagulant classes in clinical therapy?

6. What is the primary function of thrombin in the coagulation cascade?

7. Which of the following factors is NOT involved in the intrinsic pathway?

8. What clinical marker is used to monitor warfarin therapy?

9. Which class of anticoagulants includes drugs like warfarin and acts by inhibiting vitamin K-dependent clotting factors?

Révisez avec les flashcards

Approfondir avec la fiche

Cours similaires

Alterations électriques et troubles ioniques cardiaques

Fundamentos de Estafilococos y su Diagnóstico

Organisation et Fonction du Système Nerveux

Correction des troubles de la vision

Maturation folliculaire et ovulation

Fonctionnement et Spécificités des Enzymes

Crée tes propres QCM